Skip to content

Cannabis research published in 2022

Page 7 of 7: studies 121 to 133 of 133, newest first. Back to the cannabis overview

Studies

Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident

Drug Science, Policy and Law 2022 Petter Grahl Johnstad

Researchers have associated cannabis use with risk for psychosis, cognitive impairment, and traffic accident. However, this review shows that the association between moderate cannabis use and psychosis is no stronger, and often considerably weaker, than the corresponding association for moderate tobacco use. The same holds for associations with cognitive impairment. For the risk of traffic...

Perceived effects of cannabis: Generalizability of changes in driving performance.

Traffic injury prevention 2022 Thomas S Burt, Timothy L Brown, Rose Schmitt et al.

The objective of this analysis was to determine the generalizability of the relationship between different samples of a driver's perceived state after cannabis use and related performance while operating a motor vehicle. Data were collected from 52 subjects in a study examining the effects of cannabis on driving performance. Data were analyzed using the SAS GLM Select procedure, using stepwise...

Cannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects.

International review of neurobiology 2022 K Z Peters, N E Zlebnik, J F Cheer

Adolescence is a crucial developmental period where neural circuits are refined and the brain is especially vulnerable to external insults. The endocannabinoid (eCB) system undergoes changes during adolescence which affect the way in which it modulates the development of other systems, in particular dopamine circuits, which show protracted development into adolescence. Given the rise of...

Evidence of familial confounding of the association between cannabis use and cerebellar-cortical functional connectivity using a twin study.

NeuroImage: Clinical 2022 Linnea Sepe-Forrest, Dae-Jin Kim, Patrick D Quinn et al.

Cerebellar-cortical resting-state functional connectivity (rsFC) has been reported to be altered in cannabis users. However, this association may be due to genetic and environmental confounding rather than a causal relationship between cannabis use and changes in rsFC. In this co-twin control study, linear mixed models were used to assess relationships between the number of lifetime cannabis...

The Relationship Between Cannabis, Cognition, and Schizophrenia: It’s Complicated

Current Topics in Behavioral Neurosciences 2022 Hakan Kayır, Jessica Ruffolo, Patrick McCunn et al. 15 citations

America and across the globe. Cannabis use has multifaceted impacts on cognition in schizophrenia patients and healthy subjects. Healthy subjects, particularly those who initiated cannabis use at earlier ages and used high-potency cannabis for longer durations, exhibited poorer cognition mainly in working memory and attention. Cannabis use in schizophrenia has been associated with symptom...

DOI: 10.1007/7854_2022_396 (opens in new tab) Cannabidiol Effects of cannabis Cognition Schizophrenia object-oriented programming +3

Spiritual Benefit from Cannabis.

Journal of Psychoactive Drugs 2022 Frederick J. Heide, Tai Chang, Natalie Porter et al.

Like many mind-altering plants, cannabis has been part of spiritual practices for thousands of years. It has deep roots in Hinduism, Islam, Rastafarianism, and indigenous traditions in Asia, Africa, and elsewhere. Yet almost no attention has been given to how contemporary adults employ it spiritually. A sample of 1087 participants (mean age = 38.9) completed an online survey assessing their use...

Effects of cannabidiol in cannabis flower: Implications for harm reduction.

Addiction Biology 2022 Laurel P Gibson, Hollis C Karoly, Jarrod M. Ellingson et al.

Using a federally compatible, naturalistic at-home administration procedure, the present study examined the acute effects of three cannabis flower chemovars with different tetrahydrocannabinol (THC) to cannabidiol (CBD) ratios, in order to test whether chemovars with a higher CBD content produce different effects. Participants were randomly assigned to ad libitum administration of one of three...

Associations Between Cannabis, Psychosis, and Schizophrenia in Adolescents

Academic Leadership Journal in Student Research 2022 Lauren Moment, Null Null 2 citations

The effects of cannabis use on the brain, mind, and body have been studied for decades. The developing brain, particularly the adolescent and young adult brain, undergoes critical development that makes it especially susceptible to the effects of cannabis use. Among the adverse effects of cannabis use in adolescence and young adulthood, psychosis and psychotic disorders (e.g., schizophrenia)...

DOI: 10.58809/dbkn1868 (opens in new tab) Cannabidiol Psychosis Schizophrenia object-oriented programming Effects of cannabis +3

Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry.

Expert Review of Neurotherapeutics 2022 Manaswini Pillai, Simon Erridge, Lara Bapir et al. 27 citations

The current paucity of clinical evidence limits the use of cannabis-based medicinal products (CBMPs) in post-traumatic stress disorder (PTSD). This study investigates health-related quality of life (HRQoL) changes and adverse events in patients prescribed CBMPs for PTSD. A case-series of patients from the UK Medical Cannabis Registry was analyzed. HRQoL was assessed at 1-, 3-, and 6-months...

Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation

Current Topics in Behavioral Neurosciences 2022 Matthew W. Johnson 31 citations

This manuscript reviews research suggesting that classic psychedelics (5-HT2A receptor agonists) are effective in treating addictions including tobacco use disorder. I review historical research from the 1950s to 1970s suggesting that classic psychedelics are associated with addiction recovery across pharmacologically distinct drugs of addiction. I then review anthropological reports about...

Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer

Drug Science, Policy and Law 2022 Rayyan Zafar, Dustin Sulak, Jaime Brambila et al. 3 citations

A 49-year-old woman was diagnosed with an ER + , PR-, HER2 + , BRCA- invasive ductal carcinoma which progressed metastatically to include bone, liver, and lymph node involvement. Standardised care included a 26-month treatment period with targeted chemotherapy and a ketogenic diet. The patient also began a course of cannabinoid-based therapy, consisting initially of a titrated high-dose...

Aberrant Salience among Young Healthy Postgraduate University Students: The Role of Cannabis Use, Psychotic-Like Experiences, and Personality.

Psychopathology 2022 Andrea Patti, Gabriele Santarelli, Giulio D'Anna et al. 3 citations

Aberrant salience (AS) is an anomalous world experience which plays a major role in psychotic proneness. In the general population, a deployment of this construct - encompassing personality traits, psychotic-like symptoms, and cannabis use - could prove useful to outline the relative importance of these factors. For this purpose, 106 postgraduate university students filled the AS Inventory...

DOI: 10.1159/000520331 (opens in new tab) Full text (opens in new tab) Cannabis Aberrant salience Personality Psychotic-like experiences +1

Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.

Frontiers in Psychiatry 2022 Udo Bonnet, Michael Specka, Ann-Kristin Kanti et al. 4 citations

There is a lack of benefit/harm assessments of illicit and licit psychoactive substances performed by substance-dependent users in comparison to addiction medicine experts. We extended the analyses of substance harm/benefit assessments of German addiction medicine experts (N = 101), in parts reported recently in this journal [doi.org/10.3389/fpsyt.2020.59219], by the perspectives of...